Nathan Brown and Marlee Gallant Discuss Top FDA Issues for Hospitals and Health Systems in Bloomberg BNA Article
Contact:
Nathan Brown and Marlee Gallant, partner and associate, respectively, in Akin Gump’s health care and life sciences practice, have written the article “Top FDA Issues for Hospitals and Health Systems,” which was published by Bloomberg BNA’s Health Law Reporter.
The article notes that amid the rapid pace of innovation in medical technology, hospitals and health systems are increasingly engaged in activities regulated by the Food and Drug Administration (FDA). Brown and Gallant write that new laws implemented the FDA carry both opportunities and risks, and they identify five top FDA issues that health care facility managers, compliance officials and lawyers should consider this year.
To read the full article, please click here.
People Mentioned in This News
© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.